BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hub.inesc.pt - ECPv6.2.8//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:hub.inesc.pt
X-ORIGINAL-URL:https://hub.inesc.pt
X-WR-CALDESC:Events for hub.inesc.pt
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
TZID:Europe/Lisbon
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:WEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:WET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231113T090000
DTEND;TZID=Europe/Brussels:20231114T140000
DTSTAMP:20260505T135649
CREATED:20231204T130131Z
LAST-MODIFIED:20231204T130131Z
UID:12882-1699866000-1699970400@hub.inesc.pt
SUMMARY:3rd Science|Business Sector Day: Health & Life Sciences – Future-proofing medicines.
DESCRIPTION:In April this year\, the European Commission issued its proposals for a comprehensive revision of the EU’s basic pharmaceutical legislation. Reflecting key lessons learned from COVID\, the proposals seek to create  an “innovation-and competitiveness-friendly” landscape in Europe for biomedical research and medicines development\, while ensuring greater resilience and autonomy in the event of future health crises and addressing the sector’s environmental footprint.   \nYet various R&D stakeholders are concerned that – in trying to strike a balance between myriad public and private sector interests – the Commission could inadvertently achieve the opposite. For example\, shortening EU patent protection on new therapeutics is intended to boost patient access to medicines\, but could persuade pharmaceutical companies\, scientists and investors to prioritise other regions to develop and commercialise breakthrough innovations in the future. Under such a scenario\, Europe’s whole health and life sciences community is likely to feel the chill\, with fewer resources over time to sustain its historical excellence in fundamental research\, international cooperation platforms\, and global scientific leadership. Both pharmaceutical and medical technology companies are closely watching the EU’s actions on data sharing. \nWhat ultimately emerges in terms of new directives and regulation will have a direct impact on pharmaceutical and medical technology R&D ecosystems everywhere – not just in terms of corporate investment and production planning\, but also attractiveness to venture capital\, public-private partnerships and top research talent\, among others. And perhaps more importantly\, it may influence Europe’s readiness to provide global leadership – both scientific and political – when the world is confronted with its next urgent health crisis.  \nOn 15 November\, the S|B Health & Life Sciences Day will therefore take as its central theme health innovation and the future of medicines development. It will explore the state of play at the interface between healthcare legislative and regulatory agendas and their R&D equivalents. It will also feature expert roundtables and debates on specific challenges and opportunities that will influence the next era of research-industry collaboration\, including issues such as data access and sharing across borders\, and the wider implications for health and life sciences in Europe. \nParticipants profiles \n\nScience: Vice-rectors\, deans of faculty\, heads of department\, institute\, or lab\, and senior researchers\nIndustry: R&D executives overseeing key projects\, pipelines and partnerships\, EU and Government Affairs teams\nPolicy: Key representatives from European institutions\, national ministries\, innovation agencies and international organisations
URL:https://hub.inesc.pt/event/3rd-sciencebusiness-sector-day-health-life-sciences-future-proofing-medicines-3/
LOCATION:Brussels
CATEGORIES:Hybrid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20231115T093000
DTEND;TZID=Europe/Brussels:20231115T140000
DTSTAMP:20260505T135649
CREATED:20231130T132322Z
LAST-MODIFIED:20231130T132322Z
UID:12804-1700040600-1700056800@hub.inesc.pt
SUMMARY:Health & Life Science Sector Day – Health innovation and the future of medicines development Public S|B conference
DESCRIPTION:In April this year\, the European Commission issued its proposals for a comprehensive revision of the EU’s basic pharmaceutical legislation. Reflecting key lessons learned from COVID\, the proposals seek to create  an “innovation-and competitiveness-friendly” landscape in Europe for biomedical research and medicines development\, while ensuring greater resilience and autonomy in the event of future health crises and addressing the sector’s environmental footprint.   \nYet various R&D stakeholders are concerned that – in trying to strike a balance between myriad public and private sector interests – the Commission could inadvertently achieve the opposite. For example\, shortening EU patent protection on new therapeutics is intended to boost patient access to medicines\, but could persuade pharmaceutical companies\, scientists and investors to prioritise other regions to develop and commercialise breakthrough innovations in the future. Under such a scenario\, Europe’s whole health and life sciences community is likely to feel the chill\, with fewer resources over time to sustain its historical excellence in fundamental research\, international cooperation platforms\, and global scientific leadership. Both pharmaceutical and medical technology companies are closely watching the EU’s actions on data sharing. \nWhat ultimately emerges in terms of new directives and regulation will have a direct impact on pharmaceutical and medical technology R&D ecosystems everywhere – not just in terms of corporate investment and production planning\, but also attractiveness to venture capital\, public-private partnerships and top research talent\, among others. And perhaps more importantly\, it may influence Europe’s readiness to provide global leadership – both scientific and political – when the world is confronted with its next urgent health crisis.  \nOn 15 November\, the S|B Health & Life Sciences Day will therefore take as its central theme health innovation and the future of medicines development. It will explore the state of play at the interface between healthcare legislative and regulatory agendas and their R&D equivalents. It will also feature expert roundtables and debates on specific challenges and opportunities that will influence the next era of research-industry collaboration\, including issues such as data access and sharing across borders\, and the wider implications for health and life sciences in Europe. \nParticipants profiles \n\nScience: Vice-rectors\, deans of faculty\, heads of department\, institute\, or lab\, and senior researchers\nIndustry: R&D executives overseeing key projects\, pipelines and partnerships\, EU and Government Affairs teams\nPolicy: Key representatives from European institutions\, national ministries\, innovation agencies and international organisations
URL:https://hub.inesc.pt/event/health-life-science-sector-day-health-innovation-and-the-future-of-medicines-development-public-sb-conference/
LOCATION:Porto
CATEGORIES:Hybrid
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20231128
DTEND;VALUE=DATE:20231130
DTSTAMP:20260505T135649
CREATED:20231204T131802Z
LAST-MODIFIED:20231204T131802Z
UID:12886-1701129600-1701302399@hub.inesc.pt
SUMMARY:Behave 2023\, the 7th European Conference on Behaviour and Energy Efficiency by the European Energy Network (EnR).
DESCRIPTION:The event will take place in Maastricht\, the Netherlands. The theme of this year’s conference will be ‘Scaling-up Behaviour Change in the light of the energy and climate crisis’. More info
URL:https://hub.inesc.pt/event/behave-2023-the-7th-european-conference-on-behaviour-and-energy-efficiency-by-the-european-energy-network-enr/
LOCATION:Brussels
CATEGORIES:Hybrid
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Lisbon:20231130T090000
DTEND;TZID=Europe/Lisbon:20231201T170000
DTSTAMP:20260505T135649
CREATED:20231130T143600Z
LAST-MODIFIED:20231130T143600Z
UID:12851-1701334800-1701450000@hub.inesc.pt
SUMMARY:Chips Joint Undertaking Launch Event
DESCRIPTION:  \n\n\n\n\n\n\n\n\n\n\n\n\n\nThe highly anticipated launch event of the Chips Joint Undertaking\, a pioneering initiative in the realm of microelectronics and semiconductor technologies\, is getting a date shift. Originally scheduled for the 22nd and 23rd of November 2023\, the event will now take place on the 30th of November and the 1st of December 2023. The event’s location will be the Event Lounge in Brussels\, Belgium. \n? The Event Lounge\, Brussels\n? 30th November & 1st December 2023 \nThe Chips Joint Undertaking represents a collaborative endeavor with the aim of solidifying Europe’s position as a global leader in the semiconductor industry. This initiative has been conceived in response to the growing demand for advanced chip technologies and the recognition of their strategic significance across various sectors. \nThrough the European Chips Act\, the Joint Undertaking brings together prominent industry players\, esteemed research organizations\, and influential policymakers. Its primary objective is to foster synergies and drive innovation throughout the microelectronics value chain. By acting as a platform for public-private partnerships\, it facilitates collaboration and knowledge exchange to address challenges and capitalize on opportunities in the field. \nThe launch event is set to be an important occasion as it marks the official inauguration of the Chips Joint Undertaking. During these two days\, attendees will gain deep insights into the initiative’s objectives and strategic roadmap. It will offer a comprehensive understanding of the mission and program of the Chips Joint Undertaking. \nRegistration details for the event will be announced shortly. The participants are encouraged to mark their calendars and stay tuned for updates on the event agenda\, notable speakers\, and additional pertinent information. \nDon’t let this exceptional occasion pass you by. Join us at the Event Lounge in Brussels on the 30th of November and 1st of December to witness the beginning of a transformative chapter in the world of microelectronics. Together\, we can contribute to shaping the landscape of this vital industry and steer it towards a prosperous future.
URL:https://hub.inesc.pt/event/chips-joint-undertaking-launch-event/
LOCATION:Brussels
CATEGORIES:Hybrid
END:VEVENT
END:VCALENDAR